RFC4 and cancer: Like 2A-DUB/MYSM1, the newly-identified MYSM1 interaction partners, HELLS and RFC4/5, have also been implicated in tumorigenesis, specifically in melanoma growth [33]; HELLS is frequently misregulated in a variety of cancers.